COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study

Author:

Valladares-Garrido Mario J.ORCID,Zeña-Ñañez Sandra,Peralta C. IchiroORCID,Puicón-Suárez Jacqueline B.,Díaz-Vélez Cristian,Failoc-Rojas Virgilio E.

Abstract

COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28–0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference26 articles.

1. Número de Personas Fallecidas a Consecuencia Del Coronavirus a Nivel Mundial a Fecha de 23 de Septiembre de 2021, Por Continente https://es.statista.com/estadisticas/1107719/covid19-numero-de-muertes-a-nivel-mundial-por-region/

2. Respuesta de la OPS/OMS. 27 de Agosto Del 2021,2021

3. Sala Situacional COVID-19 Perú https://covid19.minsa.gob.pe/sala_situacional.asp

4. Bases moleculares de la patogénesis de Covid-19 y estudios in silico de posibles tratamientos farmacológicos;Lam-Cabanillas;Rev. De La Fac. De Med. Hum.,2021

5. Diversidad genómica en SARS-CoV-2: Mutaciones y variantes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3